BBPvsPSCHETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.29% for PSCH. BBP is up 9.25% year-to-date (YTD) with +$30M in YTD flows. PSCH performs worse with 8.5% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of BBP and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs PSCH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 06/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP PSCH | -1.38%+6.00% | +7.00%+19.98% | +9.25%+8.50% | +43.65%+16.31% | +60.05%+8.09% | +58.90%-24.67% |
| Flows | BBP PSCH | +$4M+$492K | +$26M-$3M | +$30M-$17M | +$42M-$27M | +$45M-$150M | +$38M-$235M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP PSCH | +28.75%+21.44% | +24.06%+20.54% | +24.00%+21.72% | +26.36%+22.89% |
| Max drawdown | BBP PSCH | -7.49%-4.51% | -9.59%-15.36% | -25.54%-22.80% | -37.87%-47.23% |
| Max drawdown duration | BBP PSCH | 37d13d | 48d168d | 292d478d | 760d1811d |
Trading data
BBP | PSCH | |
Last sale 6/12/2026 at 1:30 PM | $87.17 | $47.79 |
| Previous close 06/11/2026 | $86.80 | $47.74 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of May 29, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 6/12/2026 at 1:30 PM
Live
Closed
BBP | PSCH | |
|---|---|---|
| Last price | $87.17 | $47.79 |
| 1D performance | +0.42% | +0.10% |
| AuM | $78.43 M | $140.15 M |
| E/R | 0.79% | 0.29% |
Characteristics
BBP | PSCH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Products Index | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 55 | 71 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 7, 2010 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
84.13%
Other
15.87%
PSCH
USA
96.15%
Other
3.85%
Sectors
BBP
Health Care
85.97%
Other
14.03%
PSCH
Health Care
90.67%
Other
9.33%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
45.32%
PSCH
Total weight of top 15 holdings out of 15
44.63%
Top 15 holdings
Data as of April 30, 2026
BBP
ARROWHEAD PHARMACEUTICALS INC
3.17%
GB00BRXB0C07
3.17%
BIOGEN INC
3.14%
HALOZYME THERAPEUTICS
3.13%
AURINIA PHARMACEUTICALS INC
3.12%
SYNDAX PHARMACEUTICALS INC
3.12%
BIOMARIN PHARMACEUTICAL
3.05%
INCYTE
3.03%
REGENERON PHARMACEUTICALS
3.03%
BRIDGEBIO PHARMA
3.00%
SAREPTA THERAPEUTICS INC DE
2.95%
ARDELYX
2.92%
VERTEX PHARMACEUTICALS
2.85%
US07725L1026
2.83%
THERAVANCE BIOPHARMA
2.80%
PSCH
MOLINA HLTHCRE
4.96%
KRYSTAL BIOTECH INC
3.79%
GLAUKOS
3.77%
US10950A1060
3.46%
TELEFLEX
3.21%
PROTAGONIST THERAPEUTICS INC
3.11%
ALKERMES
3.00%
PTC THERAPEUTI/D
2.99%
TG THERAPEUTICS
2.59%
LIGAND PHARMACEUTICALS
2.56%
CORCEPT THERAPEUTICS
2.33%
US45579U1097
2.30%
APELLIS PHARMACEUTICALS
2.26%
RADNET
2.16%
MERIT MEDICAL SYSTEMS
2.15%
Frequently asked questions about BBP and PSCH
How have the BBP and PSCH ETFs performed in 2026?
As of June 12, 2026, BBP is up 9.25% year-to-date (YTD), while PSCH has returned 8.5%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or PSCH?
Year-to-date, the BBP ETF saw +$30M in flows, compared to -$17M for PSCH.
Which ETF is more volatile: BBP or PSCH?
Over the past year, BBP had a volatility of 24.06%, while PSCH experienced 20.54%.
Which ETF is bigger: BBP or PSCH?
As of June 12, 2026, BBP holds $78.43 M in assets under management (AUM), while PSCH manages $140.15 M.
What sectors do the BBP and PSCH ETFs invest in?
BBP leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.
What are the top holdings of the BBP ETF and PSCH ETF?
BBP top holdings include ARROWHEAD PHARMACEUTICALS INC, GB00BRXB0C07 and BIOGEN INC. PSCH holds in its top three: MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS.
Which ETF is more diversified: BBP or PSCH?
BBP holds 59 securities with 45.32% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 44.63%.
Advertisement
Advertisement
